Related Experiment Video
Updated: Feb 26, 2026
17:13
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
Published on: April 28, 2013
17.6K
Serum Uric Acid and Arterial Function After Renal Transplantation
Frederic Bauer1,2, Nikolaos Pagonas1,2, Felix S Seibert1,2
1Medical Department I, University Clinic Marienhospital Herne, Ruhr-University of Bochum, Herne, Germany.
Annals of Transplantation
|July 15, 2017
Summary
Serum uric acid (SUA) levels and SUA-lowering medication did not impact arterial stiffness in renal transplant recipients. These findings suggest that improved survival outcomes from SUA treatment are not due to direct effects on arterial function.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Pharmacology
Background:
- Hyperuricemia is linked to cardiovascular disease and chronic allograft nephropathy post-renal transplant.
- Treating asymptomatic hyperuricemia may improve patient and graft survival, but mechanisms are unclear.
- Investigating the relationship between serum uric acid (SUA) and systemic arterial function in transplant recipients is crucial.
Purpose of the Study:
- To examine the association between serum uric acid (SUA) levels and systemic arterial function in renal transplant recipients.
- To determine if SUA concentration or SUA-lowering medication affects arterial stiffness parameters.
Main Methods:
- A cross-sectional study involving 54 renal transplant recipients.
- Arterial function assessed using pulse wave analysis, including pulse wave velocity and augmentation index.
- Data analyzed for associations between SUA levels, medication use, and arterial stiffness.
Main Results:
- Prevalence of hyperuricemia was high (87.0%) with a median SUA of 7.4 mg/dL.
- No significant differences in arterial function parameters were observed between patients with SUA <7.4 mg/dL versus >7.4 mg/dL.
- No significant associations were found between SUA levels or SUA-lowering medication and arterial stiffness measures, even after adjustments.
Conclusions:
- Serum uric acid concentration and its pharmacological treatment do not appear to directly influence arterial stiffness in renal transplant recipients.
- The positive impact of SUA-lowering treatment on patient and graft survival is unlikely to be mediated by direct effects on arterial function.
Related Concept Videos
01:24Serum Studies: Renal Function Tests
507
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
507
01:17Factors Affecting Renal Clearance: Renal Impairment
526
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
526
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
69
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
69
01:26Kidney Transplant II: Surgical Procedure
537
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
537
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
376
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
376
01:29Acute Kidney Injury III: Clinical Manifestations
1.1K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K